Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-²2-glycoprotein I than with antiphospholipid antibodies - Cabiedes, J; Cabral, A; Alarcon-Segovia, D (J Rheumatol, 1995)